Form 4 for PHIO Phio Pharmaceuticals Corp.
Accepted 2026-08-20 08:30:03 ET · period of report 2026-08-19 · accession 0001683168-26-006620 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-20 08:30 | 2026-08-19 | PHIO | Plott Ronald Todd | Dir | P - Purchase | $1.14 | +15.0K | 15.0K | New | +$17.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $.0001 par value | 2026-08-19 | P | A | 15,000 | $1.14 | 15,000 | D | — | — |